Stockholm - Delayed Quote SEK
Kancera AB (publ) (KAN.ST)
1.0880
+0.0040
+(0.37%)
At close: May 9 at 5:29:52 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
14
14
1,035
753
1,704
Cost of Revenue
--
--
0
0
0
Gross Profit
--
--
1,035
753
1,704
Operating Expense
46,175
46,175
66,077
52,687
46,960
Operating Income
-46,161
-46,161
-65,042
-51,934
-45,256
Net Non Operating Interest Income Expense
1,595
1,595
153
-50
-17
Pretax Income
-44,566
-44,566
-64,889
-52,484
-45,686
Tax Provision
--
--
0
0
0
Net Income Common Stockholders
-44,566
-44,566
-64,889
-52,484
-45,686
Diluted NI Available to Com Stockholders
-44,566
-44,566
-64,889
-52,484
-45,686
Basic EPS
-0.39
-0.39
-0.81
-0.88
-0.80
Diluted EPS
-0.39
-0.39
-0.81
-0.88
-0.80
Basic Average Shares
115,332
115,332
79,620
59,533.2410
57,292.3290
Diluted Average Shares
115,332
115,332
79,620
59,533.2410
57,292.3290
Total Operating Income as Reported
-46,161
-46,161
-65,042
-51,934
-45,256
Total Expenses
46,175
46,175
66,077
52,687
46,960
Net Income from Continuing & Discontinued Operation
-44,566
-44,566
-64,889
-52,484
-45,686
Normalized Income
-44,566
-44,566
-64,889
-52,484
-45,686
Interest Income
--
--
283
68
--
Interest Expense
--
--
0
118
17
Net Interest Income
1,595
1,595
153
-50
-17
EBIT
-46,161
-46,161
-65,042
-52,366
-45,669
EBITDA
-46,161
-46,161
-62,042
-52,006
-45,349
Reconciled Cost of Revenue
--
--
0
0
0
Reconciled Depreciation
0
0
3,000
360
320
Net Income from Continuing Operation Net Minority Interest
-44,566
-44,566
-64,889
-52,484
-45,686
Normalized EBITDA
-46,161
-46,161
-62,042
-52,006
-45,349
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/25/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FLUI.ST Fluicell AB (publ)
11.50
-1.71%
DBP-B.ST Double Bond Pharmaceutical Int.
0.3750
-8.31%
TCBWF TC Biopharm (Holdings) Plc
0.0089
0.00%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
APTA.ST Aptahem AB (publ)
0.8020
+0.25%
COMBI.ST CombiGene AB (publ)
2.4800
-3.12%
QUIA.ST Quia Pharma AB (publ)
0.0089
-8.25%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0936
+1.30%
NANECH.ST NanoEcho AB
0.1158
+7.22%
ONCO.ST Oncopeptides AB (publ)
1.8240
-2.88%